CNS Pharmaceuticals, Inc. (CNSP): Cash & Equivalents
$7.20M
As of 2025-12-31
$19.98M
As of 2026-06-30
-10.5%
3-year compound annual growth
-12.5%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.20M | +11.4% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $6.46M | n/m | 2026-03-31, Balance as of period end |
| 2023-12-31 | $548.7K | -94.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $10.06M | +100.9% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $5.00M | -64.4% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $14.04M | +93.9% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $7.24M | n/m | 2021-02-12, Balance as of period end |
| 2018-12-31 | $282.7K | n/a | 2020-03-12, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | 2025-12-31 | $7.20M | +11.4% |
| GRI Bio, Inc. (GRI) | 2025-12-31 | $8.23M | +63.7% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $405.0K | -66.2% |
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | $1.56M | -67.5% |
| Revium Rx. (RVRC) | 2025-12-31 | $1.68M | -48.7% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $796.8K | -45.9% |
| Lunai Bioworks Inc. (LNAI) | 2025-06-30 | $92.7K | -58.0% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $6.81M | +72.4% |
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | $6.12M | -54.0% |
Compare CNSP, GRI, IGC, NNVC side by side · Screen every company in Pharmaceutical Preparations ↗